Trials / Terminated
TerminatedNCT02104154
Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Samsung Electronics · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
To establish the performance characteristics of the Samsung LABGEO PT10 by comparing the test results of the PT10 Hepatic assay with results obtained from an FDA-cleared chemistry analyzer.
Detailed description
To establish the correlation between measurand values as obtained from the Samsung LABGEO PT10 Hepatic Panel at the point of care, and the corresponding measurand values as obtained on a commercial clinical chemistry analyzer, with respect to prospectively collected human serum specimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Samsung LABGEO PT10 Hepatic Panel |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-04-04
- Last updated
- 2015-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02104154. Inclusion in this directory is not an endorsement.